Mayte Sánchez van Kammen

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

Mayte Sánchez van Kammen, Diana Aguiar de Sousa, Sven Poli et al. · JAMA Neurology · 2021 · 115 citations · Full text

Medicine, Hematology, Immunology +16

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)

Philip Connor, Mayte Sánchez van Kammen, Anthonie W.A. Lensing et al. · Blood Advances · 2020 · 114 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +17

Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency

Katarzyna Krzywicka, Mirjam R. Heldner, Mayte Sánchez van Kammen et al. · European Journal of Neurology · 2021 · 96 citations · Full text

Medicine, Hematology, Infectious Diseases +11

Acute symptomatic seizures in cerebral venous thrombosis

Erik Lindgren, Suzanne M. Silvis, Sini Hiltunen et al. · Neurology · 2020 · 72 citations · Full text

Medicine, Neurology, Epilepsy +12

Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS‐CoV‐2 vaccination

Anita van de Munckhof, Katarzyna Krzywicka, Diana Aguiar de Sousa et al. · European Journal of Neurology · 2021 · 50 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13